LANREOTIDE ACETATE

NDC 69097-906 · Cipla USA Inc.

Generic nameLANREOTIDE ACETATE

Dosage formINJECTION

RouteSUBCUTANEOUS

Active ingredient(s)LANREOTIDE ACETATE

Strength120 mg/.5mL

Pharmacologic classSomatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]

Marketing categoryANDA

Packages

69097-906-67 — 1 POUCH in 1 CARTON (69097-906-67) / 1 SYRINGE in 1 POUCH / .5 mL in 1 SYRINGE

Billed under HCPCS

J1930 — Injection, lanreotide, 1 mg Medicare Part B payment limit (ASP + 6%): $41.69

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

15054-1060 — lanreotide acetate, 15054-1090 — lanreotide acetate, 15054-1120 — lanreotide acetate, 69097-870 — lanreotide acetate, 69097-880 — lanreotide acetate, 69097-890 — lanreotide acetate, 69097-907 — LANREOTIDE ACETATE, 69097-908 — LANREOTIDE ACETATE, 76282-718 — LANREOTIDE ACETATE, 76282-719 — LANREOTIDE ACETATE, 76282-720 — LANREOTIDE ACETATE

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources